{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:01:30Z","timestamp":1785542490421,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,10,4]],"date-time":"2004-10-04T00:00:00Z","timestamp":1096848000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>This practice guideline was developed to provide recommendations to clinicians in Ontario on the preferred standard radiotherapy fractionation schedule for the treatment of painful bone metastases.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>A systematic review and meta-analysis was performed and published elsewhere. The Supportive Care Guidelines Group, a multidisciplinary guideline development panel, formulated clinical recommendations based on their interpretation of the evidence. In addition to evidence from clinical trials, the panel also considered patient convenience and ease of administration of palliative radiotherapy. External review of the draft report by Ontario practitioners was obtained through a mailed survey, and final approval was obtained from the Practice Guidelines Coordinating Committee.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Meta-analysis did not detect a significant difference in complete or overall pain relief between single treatment and multifraction palliative radiotherapy for bone metastases. Fifty-nine Ontario practitioners responded to the mailed survey (return rate 62%). Forty-two percent also returned written comments. Eighty-three percent of respondents agreed with the interpretation of the evidence and 75% agreed that the report should be approved as a practice guideline. Minor revisions were made based on feedback from the external reviewers and the Practice Guidelines Coordinating Committee. The Practice Guidelines Coordinating Committee approved the final practice guideline report.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>For adult patients with single or multiple radiographically confirmed bone metastases of any histology corresponding to painful areas in previously non-irradiated areas without pathologic fractures or spinal cord\/cauda equine compression, we conclude that:<\/jats:p>\n                        <jats:p>\u2022 <jats:bold>Where the treatment objective is pain relief, a single 8 Gy treatment, prescribed to the appropriate target volume, is recommended as the standard dose-fractionation schedule for the treatment of symptomatic and uncomplicated bone metastases.<\/jats:bold><\/jats:p>\n                        <jats:p>Several factors frequently considered in clinical practice when applying this evidence such as the effect of primary histology, anatomical site of treatment, risk of pathological fracture, soft tissue disease and cord compression, use of antiemetics, and the role of retreatment are discussed as qualifying statements.<\/jats:p>\n                        <jats:p>Our systematic review and meta-analysis provided high quality evidence for the key recommendation in this clinical practice guideline. Qualifying statements addressing factors that should be considered when applying this recommendation in clinical practice facilitate its clinical application. The rigorous development and approval process result in a final document that is strongly endorsed by practitioners as a practice guideline.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1471-2407-4-71","type":"journal-article","created":{"date-parts":[[2004,10,6]],"date-time":"2004-10-06T06:23:34Z","timestamp":1097043814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases \u2013 an evidence-based practice guideline"],"prefix":"10.1186","volume":"4","author":[{"given":"Jackson Sai-Yiu","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca KS","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy S","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bezjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Supportive Care Guidelines Group of Cancer Care Ontario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,10,4]]},"reference":[{"key":"161_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0167-8140(00)00238-3","volume":"56","author":"E Chow","year":"2000","unstructured":"Chow E, Danjoux C, Wong R, Szumacher E, Franssen E, Fung K, Finkelstein J, Andersson L, Connolly R: Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists. Radiother Oncol. 2000, 56: 305-314. 10.1016\/S0167-8140(00)00238-3.","journal-title":"Radiother Oncol"},{"key":"161_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S0936-6555(05)80855-6","volume":"5","author":"G Duncan","year":"1993","unstructured":"Duncan G, Duncan W, Maher EJ: Patterns of palliative radiotherapy in Canada. Clin Oncol (R Coll Radiol). 1993, 5: 92-97.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"161_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0167-8140(00)00250-4","volume":"56","author":"DE Roos","year":"2000","unstructured":"Roos DE: Continuing reluctance to use single fractions of radiotherapy for metastatic bone pain: an Australian and New Zealand practice survey and literature review. Radiother Oncol. 2000, 56: 315-322. 10.1016\/S0167-8140(00)00250-4.","journal-title":"Radiother Oncol"},{"key":"161_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0167-8140(00)00244-9","volume":"56","author":"YM van der Linden","year":"2000","unstructured":"van der Linden YM, Leer JW: Impact of randomized trial-outcome in the treatment of painful bone metastases; patterns of practice among radiation oncologists. A matter of believers vs. non-believers?. Radiother Oncol. 2000, 56: 279-281. 10.1016\/S0167-8140(00)00244-9.","journal-title":"Radiother Oncol"},{"key":"161_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0167-8140(00)00215-2","volume":"56","author":"Y Lievens","year":"2000","unstructured":"Lievens Y, Kesteloot K, Rijnders A, Kutcher G, Van den Bogaert W: Differences in palliative radiotherapy for bone metastases within Western European countries. Radiother Oncol. 2000, 56: 297-303. 10.1016\/S0167-8140(00)00215-2.","journal-title":"Radiother Oncol"},{"key":"161_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1440-1673.1995.tb00228.x","volume":"39","author":"G Stevens","year":"1995","unstructured":"Stevens G, Firth I: Patterns of fractionation for palliation of bone metastases. Australas Radiol. 1995, 39: 31-35.","journal-title":"Australas Radiol"},{"key":"161_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0936-6555(89)80036-6","volume":"1","author":"AM Crellin","year":"1989","unstructured":"Crellin AM, Marks A, Maher EJ: Why don't British radiotherapists give single fractions of radiotherapy for bone metastases?. Clin Oncol (R Coll Radiol). 1989, 1: 63-66.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"161_CR8","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0360-3016(99)00521-0","volume":"46","author":"DE Roos","year":"2000","unstructured":"Roos DE, O'Brien PC, Smith JG, Spry NA, Hoskin PJ, Burmeister BH, Turner SL, Bernshaw DM: A role for radiotherapy in neuropathic bone pain: preliminary response rates from a prospective trial (Trans-Tasman radiation oncology group, TROG 96.05). Int J Radiat Oncol Biol Phys. 2000, 46: 975-81. 10.1016\/S0360-3016(99)00521-0.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 3","key":"161_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0360-3016(00)80164-9","volume":"48","author":"P Kirkbride","year":"2000","unstructured":"Kirkbride P, Warde P, Panzarella A, Aslanidis J: A randomised trial comparing the efficacy of single fraction radiation therapy plus ondansetron with fractionated radiation therapy in the palliation of skeletal metastases [abstract]. Int J Radiat Oncol Biol Phys. 2000, 48 (Suppl 3): 185-10.1016\/S0360-3016(00)80164-9. (abst#147)","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"161_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0167-8140(99)00097-3","volume":"52","author":"Anonymous","year":"1999","unstructured":"Anonymous: 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party. Radiother Oncol. 1999, 52: 111-121. 10.1016\/S0167-8140(99)00097-3.","journal-title":"Radiother Oncol"},{"key":"161_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0167-8140(99)00110-3","volume":"52","author":"E Steenland","year":"1999","unstructured":"Steenland E, Leer JW, van Houwelingen H, Post WJ, van den Hout WB, Kievit J, de Haes H, Martijn H, Oei B, Vonk E, van der Steen-Banasik E, Wiggenraad RG, Hoogenhout J, Warlam-Rodenhuis C, van Tienhoven G, Wanders R, Pomp J, van Reijn M, van Mierlo I, Rutten E, Leer J, van Mierlo T: The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol. 1999, 52: 101-109. 10.1016\/S0167-8140(99)00110-3.","journal-title":"Radiother Oncol"},{"key":"161_CR12","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s000660050061","volume":"175","author":"S Koswig","year":"1999","unstructured":"Koswig S, Budach V: [Remineralization and pain relief in bone metastases after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study]. Strahlenther Onkol. 1999, 175: 500-508. 10.1007\/s000660050061.","journal-title":"Strahlenther Onkol"},{"key":"161_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0167-8140(98)00011-5","volume":"47","author":"OS Nielsen","year":"1998","unstructured":"Nielsen OS, Bentzen SM, Sandberg E, Gadeberg CC, Timothy AR: Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol. 1998, 47: 233-240. 10.1016\/S0167-8140(98)00011-5.","journal-title":"Radiother Oncol"},{"key":"161_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0167-8140(97)00101-1","volume":"45","author":"MN Gaze","year":"1997","unstructured":"Gaze MN, Kelly CG, Kerr GR, Cull A, Cowie VJ, Gregor A, Howard GC, Rodger A: Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. Radiother Oncol. 1997, 45: 109-116. 10.1016\/S0167-8140(97)00101-1.","journal-title":"Radiother Oncol"},{"key":"161_CR15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1200\/JCO.1995.13.2.502","volume":"13","author":"GP Browman","year":"1995","unstructured":"Browman GP, Levine MN, Mohide EA, Hayward RS, Pritchard KI, Gafni A, Laupacis A: The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol. 1995, 13: 502-512.","journal-title":"J Clin Oncol"},{"key":"161_CR16","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S0360-3016(02)04147-0","volume":"55","author":"JS Wu","year":"2003","unstructured":"Wu JS, Wong R, Johnston M, Bezjak A, Whelan T: Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys. 2003, 55: 594-605. 10.1016\/S0360-3016(02)04147-0.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"161_CR17","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1200\/JCO.1998.16.3.1226","volume":"16","author":"GP Browman","year":"1998","unstructured":"Browman GP, Newman TE, Mohide EA, Graham ID, Levine MN, Pritchard KI, Evans WK, Maroun JA, Hodson DI, Carey MS, Cowan DH: Progress of clinical oncology guidelines development using the practice guidelines development cycle: the role of practitioner feedback. J Clin Oncol. 1998, 16: 1226-1231.","journal-title":"J Clin Oncol"},{"key":"161_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0360-3016(98)00510-0","volume":"44","author":"V Ratanatharathorn","year":"1999","unstructured":"Ratanatharathorn V, Powers WE, Moss WT, Perez CA: Bone metastasis: review and critical analysis of random allocation trials of local field treatment. Int J Radiat Oncol Biol Phys. 1999, 44: 1-18. 10.1016\/S0360-3016(98)00510-0.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"161_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0360-3016(99)00397-1","volume":"46","author":"SM Bentzen","year":"2000","unstructured":"Bentzen SM, Hoskin P, Roos D, Nielsen OS: Fractionated radiotherapy for metastatic bone pain: evidence-based medicine or...?. Int J Radiat Oncol Biol Phys. 2000, 46: 681-683. 10.1016\/S0360-3016(99)00397-1.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"161_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0360-3016(99)00391-0","volume":"46","author":"E Chow","year":"2000","unstructured":"Chow E, Danjoux C, Connolly R, Andersson L, Finkelstein J, Szumacher E, Wong R: Bone metastasis: review and critical analysis of random allocation trial of local field treatment: regarding Ratanatharathorn et al. Int J Radiat Oncol Biol Phys. 2000, 46: 517-518. 10.1016\/S0360-3016(99)00391-0.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"161_CR21","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S0360-3016(00)00705-7","volume":"48","author":"JS Wu","year":"2000","unstructured":"Wu JS, Bezjak A: Bone metastases: ongoing controversies in fractionation schedules. Int J Radiat Oncol Biol Phys. 2000, 48: 908-9. 10.1016\/S0360-3016(00)00705-7.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"161_CR22","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/1097-0142(19820901)50:5<893::AID-CNCR2820500515>3.0.CO;2-Y","volume":"50","author":"D Tong","year":"1982","unstructured":"Tong D, Gillick L, Hendrickson FR: The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group. Cancer. 1982, 50: 893-899.","journal-title":"Cancer"},{"key":"161_CR23","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.1994.12.11.2345","volume":"12","author":"PW Townsend","year":"1994","unstructured":"Townsend PW, Rosenthal HG, Smalley SR, Cozad SC, Hassanein RE: Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathologic fractures due to metastatic disease. J Clin Oncol. 1994, 12: 2345-2350.","journal-title":"J Clin Oncol"},{"key":"161_CR24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00003086-198912000-00027","volume":"249","author":"H Mirels","year":"1989","unstructured":"Mirels H: Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop. 1989, 249: 256-264.","journal-title":"Clin Orthop"},{"key":"161_CR25","first-page":"120","volume":"312","author":"JA Hipp","year":"1995","unstructured":"Hipp JA, Springfield DS, Hayes WC: Predicting pathologic fracture risk in the management of metastatic bone defects. Clin Orthop. 1995, 312: 120-135.","journal-title":"Clin Orthop"},{"key":"161_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0167-8140(99)00108-5","volume":"52","author":"B Jeremic","year":"1999","unstructured":"Jeremic B, Shibamoto Y, Igrutinovic I: Single 4 Gy re-irradiation for painful bone metastasis following single fraction radiotherapy. Radiother Oncol. 1999, 52: 123-127. 10.1016\/S0167-8140(99)00108-5.","journal-title":"Radiother Oncol"},{"key":"161_CR27","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/0360-3016(94)90396-4","volume":"29","author":"NP Mithal","year":"1994","unstructured":"Mithal NP, Needham PR, Hoskin PJ: Retreatment with radiotherapy for painful bone metastases. Int J Radiat Oncol Biol Phys. 1994, 29: 1011-1014.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 2","key":"161_CR28","first-page":"163","volume":"57","author":"Y van der Linden","year":"2003","unstructured":"van der Linden Y, Lok J, Steenland E, Martijn H, Marijnen C, Leer J: Re-irradiation of painful bone metastases: a further analysis of the Dutch Bone Metastasis Study. Int J Radiat Oncol Biol Phys. 2003, 57 (Suppl 2): 163-","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"161_CR29","volume-title":"Study ID: SC20. Kingston, Ontario: NCIC","author":"National Cancer Institute of Canada Clinical Trials Group [homepage on the Internet]","year":"2004","unstructured":"National Cancer Institute of Canada Clinical Trials Group [homepage on the Internet]: Study ID: SC20. Kingston, Ontario: NCIC. 2004, [cited 2004 Apr 21], [http:\/\/www.ctg.queensu.ca\/trials\/symptom_control\/default.html]"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-4-71.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-4-71\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-4-71","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-4-71.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:36:25Z","timestamp":1728304585000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-4-71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,4]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,12]]}},"alternative-id":["161"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-4-71","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,4]]},"assertion":[{"value":"3 May 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"71"}}